PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsOrthostatic hypotension
MeSH D007024 - orthostatic hypotension
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D007022:Hypotension
$
Success rate
D054971:Orthostatic intolerance
0 Companies
0 Drugs
Success rate
D007024: 
Orthostatic hypotension
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDroxidopa Droxidopa  2021-02-18   
MylanMidodrine Midodrine  2003-09-10   
XiromedEphedrine Ephedrine  2022-04-21   
Midodrine Midodrine  2020-10-01   
Lupin ResearchDroxidopa Droxidopa  2021-02-18   
SandozEphedrine Ephedrine  2017-08-23   
TakedaMidodrine Proamatine  1996-09-06   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
14%
6/44
Phase 2
67%
4/6
Phase 3
86%
6/7
Approved: 4Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Novartis
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use